US Patent 11780907 Human antibodies to influenza hemagglutinin
Patent 11780907 was granted and assigned to Regeneron Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11780907 Human antibodies to influenza hemagglutinin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.